ATE387459T1 - Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie - Google Patents

Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie

Info

Publication number
ATE387459T1
ATE387459T1 AT01926716T AT01926716T ATE387459T1 AT E387459 T1 ATE387459 T1 AT E387459T1 AT 01926716 T AT01926716 T AT 01926716T AT 01926716 T AT01926716 T AT 01926716T AT E387459 T1 ATE387459 T1 AT E387459T1
Authority
AT
Austria
Prior art keywords
methods
compounds
lowering cholesterol
cholesterol levels
inducing hypertriglyceridemia
Prior art date
Application number
AT01926716T
Other languages
English (en)
Inventor
Vassilis Zannis
Kyriakos Kypreos
Original Assignee
Kos Pharma Inc
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/827,854 external-priority patent/US20020123093A1/en
Application filed by Kos Pharma Inc, Univ Boston filed Critical Kos Pharma Inc
Application granted granted Critical
Publication of ATE387459T1 publication Critical patent/ATE387459T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT01926716T 2000-04-06 2001-04-06 Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie ATE387459T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54438600A 2000-04-06 2000-04-06
US67908800A 2000-10-04 2000-10-04
US09/827,854 US20020123093A1 (en) 2000-04-06 2001-04-05 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia

Publications (1)

Publication Number Publication Date
ATE387459T1 true ATE387459T1 (de) 2008-03-15

Family

ID=27415432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926716T ATE387459T1 (de) 2000-04-06 2001-04-06 Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie

Country Status (9)

Country Link
US (1) US20060142200A1 (de)
EP (1) EP1274717B1 (de)
JP (1) JP2003530835A (de)
AT (1) ATE387459T1 (de)
AU (2) AU5323301A (de)
CA (1) CA2405870A1 (de)
MX (1) MXPA02009804A (de)
NO (1) NO20024769L (de)
WO (1) WO2001077136A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2377329T3 (es) * 2006-12-13 2012-03-26 The Regents Of The University Of California Mediadores selectivos y potentes del flujo de salida de colesterol
EP3842514A1 (de) * 2014-09-12 2021-06-30 Whitehead Institute for Biomedical Research Zellen zur expression von apolipoprotein e und verwendungen davon
WO2019070894A1 (en) 2017-10-03 2019-04-11 Prevail Therapeutics, Inc. GENE THERAPIES FOR LYSOSOMIAL DISORDERS
EP4251276A1 (de) * 2020-11-25 2023-10-04 Prevail Therapeutics, Inc. Gentherapien für neurodegenerative erkrankungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0669987B1 (de) * 1992-09-25 2008-08-13 Aventis Pharma S.A. Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
WO1994027612A1 (en) * 1993-05-20 1994-12-08 Baylor College Of Medicine Genetic therapy for cardiovascular disease
US5811243A (en) * 1993-08-31 1998-09-22 Duke University Methods and compositions for binding tau and MAP2c proteins
AU7142796A (en) * 1995-10-02 1997-04-28 Erasmus University Rotterdam Diagnosis method and reagents

Also Published As

Publication number Publication date
NO20024769L (no) 2002-11-26
US20060142200A1 (en) 2006-06-29
EP1274717A4 (de) 2004-07-14
AU5323301A (en) 2001-10-23
EP1274717B1 (de) 2008-02-27
WO2001077136A1 (en) 2001-10-18
MXPA02009804A (es) 2003-07-14
NO20024769D0 (no) 2002-10-03
AU2001253233B2 (en) 2006-12-07
CA2405870A1 (en) 2001-10-18
EP1274717A1 (de) 2003-01-15
JP2003530835A (ja) 2003-10-21

Similar Documents

Publication Publication Date Title
EA200501772A1 (ru) Способы измерения экспрессии генов из фиксированного и залитого в парафин образца ткани
ATE230417T1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
NO20024157L (no) Kasein-avledete peptider og anvendelser derav i terapi
DE1100895T1 (de) Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
TR200001709T2 (tr) Yeni neisseria meningitids yüzey proteini
ATE519862T1 (de) Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von gebärmutterhalskrebs
DE602004020999D1 (de) Materialien und verfahren zum einfangen von krankheitserregern und zur abtrennung von aurintricarbonsäure aus einer probe
ATE275411T1 (de) Verwendung von phyllanthus zur behandlung von chronisch entzündlichen und fibrotischen prozessen
DE60101354D1 (de) Diorganopolysiloxan/Acrylat-Copolymer enthaltende Emulsionen zur Behandlung von Flächengebilden
ATE345354T1 (de) Methode zur identifizierung von helicobacter antigenen
ATE387459T1 (de) Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie
DE69835813D1 (de) Verfahren zur kultivierung von zellen und zur vermehrung von viren
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE60334499D1 (de) Verfahren zur erhöhung der ausbreitung von b-zellen
NO20060420L (no) 2-aminobenzoylderivater
ATE437223T1 (de) Attenuiertes bovines respiratorisches syncytialvirus
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE50110552D1 (de) Verfahren zur behandlung von instabiler angina pectoris
ATE443262T1 (de) Molekulardiagnoseverfahren und behandlung von demenz mit lewy-körperchen
DE602004001047D1 (de) Phospholipidester von Clofarabin
ATE410517T1 (de) Mittel und verfahren zur expression von homologen und heterologen proteinen in rhodococcus
DE60132986D1 (de) Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie
DK1339737T3 (da) Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties